Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms

Blood (2023) 141 (23): 2824–2840.

https://doi.org/10.1182/blood.2022015653

Published: 2023

Includes: Supplemental data

Journal Articles

The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis

Oriol Alejo-Valle, Karoline Weigert, Raj Bhayadia, Michelle Ng, Hasan Issa, Christoph Beyer, Stephan Emmrich, Konstantin Schuschel, Christian Ihling, Andrea Sinz, Martin Zimmermann, Claudia Wickenhauser, Marius Flasinski, Eniko Regenyi, Maurice Labuhn, Dirk Reinhardt, Marie-Laure Yaspo, Dirk Heckl, Jan-Henning Klusmann

Blood (2022) 139 (5): 651–665.

https://doi.org/10.1182/blood.2021012231

Published: 2022

Includes: Supplemental data

Journal Articles

The Incidence of Mastocytosis in Patients with Unclear Cytopenia and/or Leucocytosis: The Hryd Study

Hannah Seemann, Nadja Jaekel, Susann Schulze, MD, Juliane Grimm, MD, Ole Vollstaedt, MD, Anja Haak, PhD, Dietger Niederwieser, MD PhD, Claudia Wickenhauser, MD, Haifa Kathrin Al-Ali, MD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-139311

Published: 2020

Journal Articles

Impact of Somatic Mutations on Outcome in Patients > 60 Years Old with Newly Diagnosed AML Treated with Response-Adapted Sequential Azacitidine and Induction Chemotherapy within the DRKS00004519 Trial (RAS-AZIC) of the East German Study Group of Hematology and Oncology (OSHO)

Nadja Jaekel, Susann Schulze, MD, Udo Siebolts, MD, Anja Haak, PhD, Nikolaos Pazaitis, MD, Michael Cross, PhD, Dietger Niederwieser, MD, Mathias Hänel, MD, Georg Maschmeyer, MD, Maxi Wass, MD, Lukas Heukamp, MB PhD, Roopika Menon, Miriam Bertrand, Claudia Wickenhauser, MD, Oana Brosteanu, PhD, Haifa Kathrin Al-Ali, MD

Blood (2019) 134 (Supplement_1): 1420.

https://doi.org/10.1182/blood-2019-127865

Published: 2019

Journal Articles

Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit

Alexander Gerbaulet, Claudia Wickenhauser, Julia Scholten, Katrin Peschke, Sebastian Drube, Hans-Peter Horny, Thomas Kamradt, Ronald Naumann, Werner Müller, Thomas Krieg, Claudia Waskow, Karin Hartmann, Axel Roers

Blood (2011) 117 (6): 2012–2021.

https://doi.org/10.1182/blood-2008-11-189605

Published: 2011

Includes: Supplemental data

Journal Articles

Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients.

Thoralf Lange, MD, Anja Edelmann, Uwe Siebolts, Claudia Nehring, Nadja Jäckel, Michael Cross, Maier Jacqueline, Dietger Niederwieser, Claudia Wickenhauser

Blood (2010) 116 (21): 3462.

https://doi.org/10.1182/blood.V116.21.3462.3462

Published: 2010

Journal Articles

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Elvira Edel, Claudia Wickenhauser, Mark Westerman, Sabine Leiblein, Uwe Gerd Liebert, Marianne Hehme, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1307.

https://doi.org/10.1182/blood.V116.21.1307.1307

Published: 2010

Journal Articles

Establishment of a Highly Sensitive Allele Specific Wild Type Blocker Polymerase Chain Reaction Followed by Pyrosequencing for Detection of the p.D816V Point Mutation.

Udo Siebolts, MD, MSc, Haifa Kathrin Al-Ali, MD, Dietger Niederwieser, MD, Claudia Wickenhauser, MD

Blood (2009) 114 (22): 4975.

https://doi.org/10.1182/blood.V114.22.4975.4975

Published: 2009

Journal Articles

Overexpression of TOSO in CLL Is Triggered by B-Cell Receptor Signaling and Associated with Progressive Disease.

Christian P Pallasch, MD, Alexandra Schulz, Nadine Kutsch, Janine Schwamb, Susanne Hagist, MD, Claudia Wickenhauser, MD, Alfred Ultsch, PhD, Hamid Kashkar, PhD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2008) 112 (11): 2070.

https://doi.org/10.1182/blood.V112.11.2070.2070

Published: 2008

Journal Articles

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease

Christian Philipp Pallasch, Alexandra Schulz, Nadine Kutsch, Janine Schwamb, Susanne Hagist, Hamid Kashkar, Alfred Ultsch, Claudia Wickenhauser, Michael Hallek, Clemens-Martin Wendtner

Blood (2008) 112 (10): 4213–4219.

https://doi.org/10.1182/blood-2008-05-157255

Published: 2008

Includes: Supplemental data

Journal Articles

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

Michael S. von Bergwelt-Baildon, Alexey Popov, Tomo Saric, Jens Chemnitz, Sabine Classen, Marc S. Stoffel, Francesca Fiore, Udo Roth, Marc Beyer, Svenja Debey, Claudia Wickenhauser, Franz-Georg Hanisch, Joachim L. Schultze

Blood (2006) 108 (1): 228–237.

https://doi.org/10.1182/blood-2005-08-3507

Published: 2006

Includes: Supplemental data

Journal Articles

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma

Peter Borchmann, Roland Schnell, Irene Fuss, Oliver Manzke, Thomas Davis, Lionel D. Lewis, Detlev Behnke, Claudia Wickenhauser, Petra Schiller, Volker Diehl, Andreas Engert

Blood (2002) 100 (9): 3101–3107.

https://doi.org/10.1182/blood-2001-12-0295

Published: 2002

Journal Articles

Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death

Udo F. Hartwig, Michael Robbers, Claudia Wickenhauser, Christoph Huber

Blood (2002) 99 (8): 3041–3049.

https://doi.org/10.1182/blood.V99.8.3041

Published: 2002

NARROW

Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms

The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis

The Incidence of Mastocytosis in Patients with Unclear Cytopenia and/or Leucocytosis: The Hryd Study

Impact of Somatic Mutations on Outcome in Patients > 60 Years Old with Newly Diagnosed AML Treated with Response-Adapted Sequential Azacitidine and Induction Chemotherapy within the DRKS00004519 Trial (RAS-AZIC) of the East German Study Group of Hematology and Oncology (OSHO)

Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit

Milestones of Post Transplant Monitoring of JAK2 p.V617F Positive MPN Patients.

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Establishment of a Highly Sensitive Allele Specific Wild Type Blocker Polymerase Chain Reaction Followed by Pyrosequencing for Detection of the p.D816V Point Mutation.

Overexpression of TOSO in CLL Is Triggered by B-Cell Receptor Signaling and Associated with Progressive Disease.

Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma

Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only